Does Rallies show 13F holders for COEP?

Yes. Rallies tracks hedge fund and 13F ownership data for COEP, including fund names, share counts, latest tracked quarter, and position changes when available.

Is COEP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for COEP. It does not provide personalized investment advice.

COEP (Coeptis Therapeutics Holdings Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) is a publicly traded Healthcare sector company. As of May 21, 2026, COEP trades at $16.40 with a market cap of $102.06M and a P/E ratio of -6.51. COEP moved +1.05% today. Year to date, COEP is +6.49%; over the trailing twelve months it is +31.52%. Its 52-week range spans $2.31 to $21.41. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces COEP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns COEP stock?

Hedge funds tracked by Rallies that own COEP include Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Coeptis Therapeutics Holdings Inc. Common Stock.

COEP Key Metrics

Key financial metrics for COEP
Metric	Value
Price	$16.40
Market Cap	$102.06M
P/E Ratio	-6.51
EPS	$-2.52
Dividend Yield	0.00%
52-Week High	$21.41
52-Week Low	$2.31
Volume	111.93K
Avg Volume	0
Revenue (TTM)	$1.41M
Net Income	$-12.93M
Gross Margin	87.22%

Top Hedge Funds Holding COEP

Citadel Advisors holds 111.34K shares of COEP, changed +390.26% as of Sep 30, 2024.

Latest COEP News

Z Squared Merges with Coeptis, Lists 51.5 Million Shares on Nasdaq on April 27 — Apr 24, 2026
Nasdaq Approves Listing for Post-Merger Coeptis Stock, Merger Expected Q2 2026 — Apr 7, 2026

Recent COEP Insider Trades

DeSilva Tara bought 466 (~$260.96) on Jan 12, 2024.
DeSilva Tara bought 1.80K (~$1.04K) on Jan 12, 2024.
Cogley Brian bought 5.00K (~$3.35K) on Jan 10, 2024.

COEP Analyst Consensus

1 analysts cover COEP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.

Common questions about COEP

Who owns COEP stock?: Hedge funds tracked by Rallies that own COEP include Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Coeptis Therapeutics Holdings Inc. Common Stock.
Does Rallies show 13F holders for COEP?: Yes. Rallies tracks hedge fund and 13F ownership data for COEP, including fund names, share counts, latest tracked quarter, and position changes when available.
Is COEP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for COEP. It does not provide personalized investment advice.